Effect of Caloric Restriction on Myocardial Fatty Acid Uptake, Left Ventricular Mass, and Cardiac Work in Obese Adults

American Journal of Cardiology

Volumn 103, Issue 12, 2009, Pages 1721-1726

  Viljanen, Antti P M ^a   Karmi, Anna ^a   Borra, Ronald ^a   Pärkkä, Jussi P ^a   Lepomäki, Virva ^a   Parkkola, Riitta ^a   Lautamäki, Riikka ^a   Järvisalo, Mikko ^a   Taittonen, Markku ^a   Rönnemaa, Tapani ^a   Iozzo, Patricia ^a,b   Knuuti, Juhani ^a   Nuutila, Pirjo ^a   Raitakari, Olli T ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FLUORINE 18; FLUORO 6 THIAHEPTADECANOIC ACID F 18; FLUORODEOXYGLUCOSE F 18; INSULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CALORIC RESTRICTION; CLINICAL ARTICLE; CLINICAL EVALUATION; DIET; FATTY ACID TRANSPORT; FEMALE; GLUCOSE TRANSPORT; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART WORK; HUMAN; INSULIN SENSITIVITY; LOW CALORY DIET; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; WHOLE BODY AUTORADIOGRAPHY;

ADULT; CALORIC TESTS; DIET, FAT-RESTRICTED; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; OBESITY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; WEIGHT LOSS;

EID: 67649395608     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.025     Document Type: Article

References (29)

1. Mazumder P.K., O'Neill B.T., Roberts M.W., Buchanan J., Yun U.J., Cooksey R.C., Boudina S., and Abel E.D. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53 (2004) 2366-2374
2. Aasum E., Hafstad A.D., Severson D.L., and Larsen T.S. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52 (2003) 434-441
3. Unger R.H. Lipotoxic diseases. Annu Rev Med 53 (2002) 319-336
4. Zhou Y.T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., Orci L., and Unger R.H. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97 (2000) 1784-1789
5. Carroll J.F., and Tyagi S.C. Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. Am J Hypertens 18 (2005) 692-698
6. Kankaanpää M., Lehto H.R., Pärkkä J.P., Komu M., Viljanen A., Ferrannini E., Knuuti J., Nuutila P., Parkkola R., and Iozzo P. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91 (2006) 4689-4695
7. Peterson L.R., Herrero P., Schechtman K.B., Racette S.B., Waggoner A.D., Kisrieva-Ware Z., Dence C., Klein S., Marsala J., Meyer T., et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109 (2004) 2191-2196
8. Hammer S., Snel M., Lamb H.J., Jazet I.M., van der Meer R.W., Pijl H., Meinders E.A., Romijn J.A., de Roos A., and Smit J.W. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 52 (2008) 1006-1012
9. Mäki M., Nuutila P., Laine H., Voipio-Pulkki L.M., Haaparanta M., Solin O., and Knuuti J.M. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease. Diabetes 46 (1997) 1491-1496
10. Laine H., Raitakari O.T., Niinikoski H., Pitkanen O.P., Iida H., Viikari J., Nuutila P., and Knuuti J. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 32 (1998) 147-153
11. Mäki M.T., Haaparanta M., Nuutila P., Oikonen V., Luotolahti M., Eskola O., and Knuuti J.M. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid. J Nucl Med 39 (1998) 1320-1327
12. Stolen K.Q., Kemppainen J., Kalliokoski K.K., Luotolahti M., Viljanen T., Nuutila P., and Knuuti J. Exercise training improves insulin-stimulated myocardial glucose uptake in patients with dilated cardiomyopathy. J Nucl Cardiol 10 (2003) 447-455
13. Takala T.O., Nuutila P., Pulkki K., Oikonen V., Grönroos T., Savunen T., Vähäsilta T., Luotolahti M., Kallajoki M., Bergman J., et al. 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle. Eur J Nucl Med Mol Imaging 29 (2002) 1617-1622
14. Viljanen A.P., Lautamäki R., Järvisalo M., Parkkola R., Huupponen R., Lehtimäki T., Rönnemaa T., Raitakari O.T., Iozzo P., and Nuutila P. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects. Ann Med 14 (2008) 1-9
15. Viljanen A.P., Iozzo P., Borra R., Kankaanpää M., Karmi A., Lautamäki R., Järvisalo M., Parkkola R., Rönnemaa T., Guiducci L., et al. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. J Clin Endocrinol Metab 94 (2009) 50-55
16. Iida H., Takahashi A., Tamura Y., Ono Y., and Lammertsma A.A. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 36 (1995) 78-85
17. Iida H., Rhodes C.G., de Silva R., Araujo L.I., Bloomfield P.M., Lammertsma A.A., and Jones T. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 33 (1992) 1669-1677
18. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlak C.S., Pettigrew K.D., Sakurada O., and Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28 (1977) 897-916
19. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30 (1993) 672-679
20. Szczepaniak L.S., Babcock E.E., Schick F., Dobbins R.L., Garg A., Burns D.K., McGarry J.D., and Stein D.T. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276 (1999) E977-E989
21. Thomsen C., Becker U., Winkler K., Christoffersen P., Jensen M., and Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12 (1994) 487-495
22. Alfakih K., Reid S., Jones T., and Sivananthan M. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol 14 (2004) 1813-1822
23. Leichman J.G., Aguilar D., King T.M., Vlada A., Reyes M., and Taegtmeyer H. Association of plasma free fatty acids and left ventricular diastolic function in patients with clinically severe obesity. Am J Clin Nutr 84 (2006) 336-341
24. Borradaile N.M., and Schaffer J.E. Lipotoxicity in the heart. Curr Hypertens Rep 7 (2005) 412-417
25. Christoffersen C., Bollano E., Lindegaard M.L., Bartels E.D., Goetze J.P., Andersen C.B., and Nielsen L.B. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144 (2003) 3483-3490
26. Ouwens D.M., Boer C., Fodor M., de Galan P., Heine R.J., Maassen J.A., and Diamant M. Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signaling in rats. Diabetologia 48 (2005) 1229-1237
27. Opie L.H. The Heart. 3rd ed. (1998), Lippincott-Raven, Philadelphia, Pennsylvania
28. Nuutila P., Koivisto V.A., Knuuti J., Ruotsalainen U., Teras M., Haaparanta M., Bergman J., Solin O., Voipio-Pulkki L.M., and Wegelius U. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89 (1992) 1767-1774
29. Knuuti M.J., Maki M., Yki-Jarvinen H., Voipio-Pulkki L.M., Harkonen R., Haaparanta M., and Nuutila P. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 27 (1995) 1359-1367